Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 years or older, of any gender
- People who have been formally diagnosed with a type of blood cancer called a mature B-cell tumor, as defined by World Health Organization (WHO) 2008 guidelines
- People who are able and willing to attend and follow all required study appointments and procedures
- People who have read, understood, and signed a consent form agreeing to take part in the study
Who may not be able to join:
- No exclusion criteria were listed in the provided information (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Davide Rossi, MD, PhD, Oncology Institute of Southern Switzerland
Phone: +41 091 811 8540
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Accuracy of interim plasma cell free DNA genotyping for cHL patients; Accuracy of interim plasma cell free DNA genotyping for DLBCL patients; Accuracy of interim plasma cell free DNA genotyping for FL patients; Accuracy of interim plasma cell free DNA genotyping for MCL patients
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.